Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Alnylam Pharmaceuticals (NQ: ALNY ) 277.33 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Alnylam Pharmaceuticals < Previous 1 2 ... 8 9 10 11 12 13 14 15 Next > Alnylam Posts Mid-Stage Study Data From Regeneron-Partnered Kidney Disease Drug August 29, 2022 Via Benzinga 10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others August 29, 2022 These names are benefitting from M&A, clinical data and promising regulatory actions. Via Investor's Business Daily Alnylam Reports Positive Results from Phase 2 Study of Investigational Cemdisiran for the Treatment of IgA Nephropathy August 29, 2022 From Alnylam Pharmaceuticals, Inc. Via Business Wire Moderna Entangles Pfizer/BioNTech In COVID-19 Vaccine Patent Lawsuits: All You Need To Know August 26, 2022 Moderna Inc (NASDAQ: MRNA) has Via Benzinga Where Alnylam Pharmaceuticals Stands With Analysts August 04, 2022 Within the last quarter, Alnylam Pharmaceuticals (NASDAQ:ALNY) has observed the following analyst ratings: Via Benzinga Why Is Alnylam (ALNY) Stock Up 50% Today? August 03, 2022 ALNY stock is quickly moving higher as Wall Street weighs Alnylam's encouraging results for a hard-to-treat condition. Via InvestorPlace Alnylam Announces Appointment of Elliott Sigal, M.D., Ph.D., to Board of Directors August 24, 2022 From Alnylam Pharmaceuticals, Inc. Via Business Wire Alnylam to Present Data from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at the 18th International Symposium on Amyloidosis August 18, 2022 From Alnylam Pharmaceuticals, Inc. Via Business Wire Will Investors Notice Exciting Sign On Alnylam Pharmaceuticals Chart? August 17, 2022 If history is any guide, there may be good fortune ahead for shares of Alnylam Pharmaceuticals (NASDAQ:ALNY). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be... Via Benzinga If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,000 Today August 12, 2022 Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 15 years by 9.06% on an annualized basis producing an average annual return of 16.5%. Currently, Alnylam... Via Benzinga Pfizer Is Reportedly In 'Advanced Talks' To Buy Global Blood Therapeutics For $5 Billion August 05, 2022 Shares of Pfizer's rumored takeover target have rocketed for two days running. Via Investor's Business Daily Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review August 05, 2022 The Nasdaq and small caps rose while the S&P 500 is hitting resistance. Via Investor's Business Daily Alnylam's Hot Streak Cools As Expert Questions Uptake For Its Heart Drug August 05, 2022 The company will compete with Pfizer, which already has an approved drug. Via Investor's Business Daily Intellia Gives Back Alnylam-Inspired Gains As Gene-Editing Safety Questioned August 04, 2022 Intellia is backing off the higher dose of a gene-editing drug in cardiomyopathy patients. Via Investor's Business Daily Alnylam Pharmaceuticals Earnings Perspective: Return On Capital Employed August 04, 2022 Alnylam Pharmaceuticals (NASDAQ:ALNY) brought in sales totaling $224.82 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 15.42%, resulting in a loss of $277.40... Via Benzinga Moderna, PayPal And Some Other Big Gainers From Wednesday August 04, 2022 U.S. stocks closed higher on Wednesday, with the Dow Jones gaining more than 400 points. Here is the list of some big stocks moving higher in the previous session. Via Benzinga This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday August 04, 2022 Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume. Via Benzinga Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary August 03, 2022 Via Benzinga Why Are Gene Editing Stocks NTLA, ALNY, CRSP, BEAM Up Today? August 03, 2022 Gene editing stocks are a bright spot on the market today after Alnylam announced the success of one of its RNAi therapies, Patisiran. Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's Intraday Session August 03, 2022 Via Benzinga What Is Going on With Helius Medical (HSDT) Stock Today? August 03, 2022 Helius Medical (HSDT) stock is rocketing higher on Wednesday despite a lack of news from the medical device holding company. Via InvestorPlace Alnylam Shares Shoot Higher Following Positive Clinical Results From Late-Stage ATTR Amyloidosis Therapeutics August 03, 2022 Alnylam (NASDAQ: ALNY) announced positive results from the APOLLO-B Phase 3 study of Patisiran for the treatment of transthyretin-mediated (ATTR) amyloidosis with cardiomyopathy. Via Benzinga Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session August 03, 2022 Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday. Via Benzinga Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial August 03, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Alnylam Pharmaceuticals Is On Track To Hit A Record High — Here's Why August 03, 2022 Alnylam stock is on track to open at a record high Wednesday after its cardiomyopathy drug met every goal in a final-phase study. Via Investor's Business Daily Why Alnylam Pharma Shares Are Trading Higher During Premarket Session August 03, 2022 Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) shares are rallying after upbeat data from APOLLO-B Phase 3 study of patisiran for transthyretin-mediated (ATTR) amyloidosis with cardiomyopathy. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session August 03, 2022 Via Benzinga Alnylam Reports Positive Topline Results from APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy August 03, 2022 From Alnylam Pharmaceuticals, Inc. Via Business Wire Alnylam Ranks #1 on Fast Company’s Fourth Annual List of the 100 Best Workplaces for Innovators August 02, 2022 From Alnylam Pharmaceuticals, Inc. Via Business Wire 10 Health Care Stocks Whale Activity In Today's Session July 28, 2022 This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... Via Benzinga < Previous 1 2 ... 8 9 10 11 12 13 14 15 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.